NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

放射治療市場 - 預測(2021年∼2026年)

Radiotherapy Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023219
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
放射治療市場 - 預測(2021年∼2026年) Radiotherapy Market - Forecasts from 2021 to 2026
出版日期: 2021年07月09日內容資訊: 英文 110 Pages
簡介

全球放射治療的市場規模,從2019年的80億5,800萬美元,預計到2026年達到138億6,100萬美元,在預期期間以8.06%的年複合成長率發展。

全球放射治療市場成長,由於治療費的削減,癌症患者增加,對癌症治療的研究開發的大規模投資,治療中非侵入性治療的開發等所帶動。同時,有替代治療,轉移狀態的癌症不能使用,有皮膚斑疹等副作用等,妨礙全球放射治療市場。

本報告提供全球放射治療市場調查,市場概要和趨勢,市場成長要素與阻礙因素,主要企業的簡介和競爭情形,各治療方法、應用、終端用戶、地區的市場分析。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 前提條件

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特五力分析
    • 終端用戶的交易
    • 購買企業的競爭力
    • 新加入業者的威脅
    • 替代品的威脅
    • 產業的競爭企業間的競爭關係
  • 產業的價值鏈分析

第5章 各治療法:放射治療的市場分析

  • 簡介
  • 體外放射治療
  • 體內放射療法/近接治療
  • 全身放射線治療

第6章 各應用領域:放射治療的市場分析

  • 簡介
  • 前列腺癌症
  • 乳癌
  • 肺癌症
  • 頭頸椎癌症
  • 其他

第7章 各終端用戶:放射治療的市場分析

  • 簡介
  • 醫院
  • 門診病人手術中心
  • 其他

第8章 各地區:放射治療的市場分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第9章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,共同研究
  • 供應商的競爭力 矩陣

第10章 企業簡介

  • Elekta AB
  • Accuray Incorporated
  • Ion Beam Applications (IBA)
  • Isoray Medical, Inc.
  • Canon Medical Systems Corporation
  • Mirada Medical
  • Eckert & Ziegler
  • Siemens Healthineers
  • Varian Medical Systems, Inc
  • Mevion Medical Systems, Inc.
目錄
Product Code: KSI061610003

The global radiotherapy market is evaluated at US$8.058 billion for the year 2019 growing at a CAGR of 8.06% reaching a market size of US$13.861 billion by the year 2026.

The global radiotherapy market growth is expected to be driven by the reduction in treatment cost, the increase in cancer cases, large-scale investments in R&D for cancer treatments, and the development of non-invasive procedures for treatment. The factors such as availability of alternative therapy, inability to be used for metastasis state of cancer, and side effects like skin rashes are likely to hinder the global radiotherapy market.

A key factor expected to be responsible for market growth is the rise in the number of cancer cases at a global level. Cancer is one of the major life-threatening diseases of our times. According to the World Health Organization, cancer is the second leading cause of death, globally, and was responsible for an estimated 9.6 million deaths in 2018. Globally, about one in six deaths are due to cancer. Approximately 70% of deaths from cancer occur in low and middle-income countries. Head and neck cancer account for nearly 5-6% of the cancer cases in the United States. It is the 15th most prevalent type of cancer in Europe, with nearly 56,000 cases diagnosed annually.

However, inadequate resources to meet the demands of radiotherapy and a lack of skilled, experienced professionals, to carry out the workload, are observed across all the major markets. The actual number of skilled personnel required to perform a radiotherapy procedure depends not only on the number of patients treated but also on other factors, such as the complexity of the treatment and the nature of the local equipment.

The demand for radiotherapy treatment increased in the United States over the years with a significant rise in the number of cancer cases. According to a report by the Centers for Disease Control & Prevention, the number of cancer cases increased from 15,74,811 in 2010 to 17,08,921 in 2018.

The advent of COVID-19 had an adverse impact on the global radiotherapy market.

The immense downturn in the global radiation oncology sites is due to the widespread scare of the pandemic during the year 2020. This restricted their movements and patients preferred to stay at home to reduce exposure. Even though the radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO). All 222 physician leaders in the survey, which was in the field April 16-30, said their practices continued to provide radiation therapy services during the early weeks of the pandemic, yet 85% also reported declines in the number of patients seen, by an average of one-third. Similarly, according to research by the University of Leeds, with Public Health England and the Royal College of Radiologists, reveals that there was a decrease in radiotherapy treatment courses of 19.9% in April, 6.2% in May, and 11.6% in June 2020, compared with the same months the previous year in England. The study also highlighted that the greater use of hypofractionated dosing regimens has helped radiation oncology sites deliver radiation therapy to cancer patients in England during the COVID-19 pandemic, offsetting a massive decline in treatment sessions overall. With the world recovering from the pandemic, many patients are expected to resume their treatments starting from the second quarter of 2021. This trend is expected to continue during the forecast period as well.

Asia Pacific region is expected to grow at a significant pace during the forecast period.

The rise in the demand for radiotherapy treatment in the region is major because of the exponential rise in the number of cancer cases in the region. According to a report published by the Cancer Atlas, in 2018, 8.2 million new cancer cases and 5.2 million cancer deaths were estimated in the region, corresponding to around half of the cancer burden worldwide. China alone accounted for 52% of new cancer cases (4.3 million) and 55% of cancer deaths (2.9 million) in the region. Overall, cancers of the lung (1,166,200 new cases, 15% of all cases), colorectum (914,200, 11%) and female breast (845,400, 10%) are the most common cancers. Lung cancer remains the leading cause of death (1,013,100 deaths, 21% of all deaths), followed by stomach (560,500, 11%) and liver cancer (554,000, 11%). Moreover, the region contributes to more than half of all cancer cases worldwide. This indicates the increasing adoption of radiotherapy measures in order to curb the disease in the coming years.

Market Segmentation:

  • By Therapy type

External Beam Radiotherapy

Internal Beam Radiotherapy/Brachytherapy

Systemic Radiotherapy

  • By Application

Prostate Cancer

Breast Cancer

Lung Cancer

Head And Neck Cancer

Others

  • By End user

Hospitals

Ambulatory Surgical Centres

Others

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Others

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Radiotherapy Market Analysis, by Therapy type

  • 5.1. Introduction
  • 5.2. External Beam Radiotherapy
  • 5.3. Internal Beam Radiotherapy/Brachytherapy
  • 5.4. Systemic Radiotherapy

6. Radiotherapy Market Analysis, by Application

  • 6.1. Introduction
  • 6.2. Prostate Cancer
  • 6.3. Breast Cancer
  • 6.4. Lung Cancer
  • 6.5. Head And Neck Cancer
  • 6.6. Others

7. Radiotherapy Market Analysis, by End-user

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centres
  • 7.4. Others

8. Radiotherapy Market Analysis, by Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. UK
    • 8.4.4. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles

  • 10.1. Elekta AB
  • 10.2. Accuray Incorporated
  • 10.3. Ion Beam Applications (IBA)
  • 10.4. Isoray Medical, Inc.
  • 10.5. Canon Medical Systems Corporation
  • 10.6. Mirada Medical
  • 10.7. Eckert & Ziegler
  • 10.8. Siemens Healthineers
  • 10.9. Varian Medical Systems, Inc
  • 10.10. Mevion Medical Systems, Inc.